Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Today, bitcoin rips past $82,000 as oil prices slump on de-escalation headlines, fueling a wave of short-covering and...
A coalition of five major U.S. banking trade groups is mounting a coordinated push against the CLARITY Act's stableco...
Policy makers unveiled tax measures aimed at tech profits, rattling a rally that earned the nickname the hottest stoc...
Dell Technologies is redefining value by leaning into AI-ready data centers. In the latest results, Dell’s Infrastruc...
Nvidia delivered record 2026 results as demand for AI-driven data centers surged, yet regulatory and geopolitical hea...
As visa rules tighten, a growing share of U.S. firms with immigrant leaders are scrambling to secure continuity throu...
The AI boom often centers on GPUs and big models, but the true mover is the network that ties data and compute togeth...
A Reagan Institute survey shows two-thirds of voters are upbeat on American-led innovation, spanning parties and gene...
Anthropic's Claude Opus Here: Opus 4.8 brings sharper reasoning and tighter alignment without a price change. This de...
A seasoned guitarist turns to AI tools to demo and arrange music after Parkinson's limits his hands. The move undersc...
Oil majors are again tightening the net on mid-cap energy producers. Three energy plays stand out as takeover candida...